Harbour Capital Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$971K Buy
57,950
+29,300
+102% +$491K 0.2% 108
2025
Q1
$384K Buy
+28,650
New +$384K 0.09% 197